Enfusion Inc is a technology company that provides a comprehensive investment management platform designed to streamline operations for asset managers, fund administrators, and financial institutions
Their services include portfolio management, trade execution, risk analytics, and reporting solutions, all of which are integrated into a single, cloud-based platform. By leveraging advanced technology and data analytics, Enfusion aims to enhance operational efficiency and improve decision-making for its clients in the rapidly evolving financial landscape.
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Feb. 26 through March 1.
Goldman Sachs downgrades Enfusion from Neutral to Sell, lowers price target from $9 to $8, expects stock to be range-bound in 2024 with slower growth than Street estimates due to company-specific challenges. Analyst will watch for improvements to become more positive on the stock.
U.S. stocks closed slightly lower on Friday, but the S&P 500 closed out last year with a gain of 24.2%. The Dow closed the year with a 13.7% gain, while the Nasdaq Composite surged 43.4% to record its best year since 2020.
